Noubar Afeyan sold $703k of MRNA
director at Moderna, Inc.. 23,853 shares at an average of $29.49, traded Dec 11, 2025, filed Dec 15, 2025.
Score components
- +15RoleDirector
- +21Trade size$703k at market
- +20Share of holdings soldSold 86% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +35.6%, 3m +78.2%, 6m +74.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-25-318567, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 11, 2025 | MOption exercise Common Stockindirect: By Flagship Pioneering, Inc. | +23,853 | $10.90 | $260k | 27,777 | Dec 15, 2025 |
| Dec 11, 2025 | SOpen-market sale Common Stockindirect: By Flagship Pioneering, Inc. | -23,853 | $29.49 | $703k | 3,924 | Dec 15, 2025 |
| Dec 11, 2025 | MOption exercise Stock Option (Right to Buy)derivativeindirect: By Flagship Pioneering, Inc. | -23,853 | $0.00 | $0 | 0 | Dec 15, 2025 |
Related signals
Other insiders at Moderna, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | Moderna, Inc. | Stephen Hoge President | $12M 80,575 shares | -5% | |
| 37Weak | Moderna, Inc. | James M Mock Chief Financial Officer | $4.7M 34,836 shares | -37% | |
| 13Weak | Moderna, Inc. | Shannon Thyme Klinger Chief Legal Officer | $486k 3,471 shares | -4% | |
| 15Weak | Moderna, Inc. | Stephane Bancel Chief Executive Officer | $29M 499,246 shares | -7% | |
| 10Weak | Moderna, Inc. | Stephen Hoge President | $3.6M 53,336 shares | -3% | |
| 18Weak | Moderna, Inc. | Stephen Hoge President | $2.7M 53,336 shares | -3% | |
| 6Weak | Moderna, Inc. | Shannon Thyme Klinger Chief Legal Officer | $174k 3,471 shares | -5% | |
| 52Moderate | Moderna, Inc. | Noubar Afeyan director | $434k 9,263 shares | -70% | |
| 25Weak | Moderna, Inc. | Stephen Hoge President | $2.6M 53,336 shares | -3% | |
| 11Weak | Moderna, Inc. | Abbas Hussain director | $265k 5,682 shares | -32% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.